Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Michigan Advanced Psychiatry is a private, multi-site outpatient psychiatry practice focused on interventional and medication-based treatment for mental health disorders. The clinic offers transcranial magnetic stimulation, including Deep TMS, Spravato (esketamine), IV ketamine, medication management, and integrative psychiatry services. Its clinical focus is on patients with depression, anxiety, PTSD, OCD, and related conditions, particularly those who have not responded adequately to first-line treatments. The organization operates in Michigan and Indiana, with locations in Ann Arbor, Troy, East Lansing/Lansing, and Fort Wayne. Rather than a drug-development biotech, it is a healthcare delivery company providing commercial psychiatric care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Michigan Advanced Psychiatry.